Metalloproteases and inhibitors in arthritic diseases (Q24292230)

ADAM metallopeptidase with thrombospondin type 1 motif 3

Europe PubMed Central

title

Metalloproteases and inhibitors in arthritic diseases (English)

0 references

main subject

1 reference

Best Practice & Research: Clinical Rheumatology

GOA release 2020-03-11

author name string

J Martel-Pelletier

series ordinal

1

0 references

D J Welsch

series ordinal

2

0 references

J P Pelletier

series ordinal

3

0 references

language of work or name

English

0 references

publication date

December 2001

0 references

published in

0 references

volume

15

0 references

issue

5

0 references

page(s)

805-29

0 references

cites work

Interleukin-1beta-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1beta and interleukin-18

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate–induced invasion in mouse keratinocytes

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Classification of peptidases

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide, of streptococcal cell wall-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA.

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

ICEBERG: a novel inhibitor of interleukin-1beta generation

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Metalloprotease-Disintegrins: Links to Cell Adhesion and Cleavage of TNFα and Notch

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

The AP-1 site and MMP gene regulation: what is all the fuss about?

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Matrix metalloproteinase inhibitors: Present achievements and future prospects

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Furin-dependent intracellular activation of the human stromelysin-3 zymogen

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Caspase-1 (interleukin-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP)

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Fibronectin-mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation. The signaling role of protein kinase C-beta

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Wanted--the collagenase responsible for the destruction of the collagen network in human cartilage!

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Engineering of selective TIMPs

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

MMP inhibition and downregulation by bisphosphonates.

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

1 reference

https://api.crossref.org/works/10.1053/BERH.2001.0195

7 January 2021

Identifiers

DOI

10.1053/BERH.2001.0195

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

11812023

1 reference

Consolidated OpenCitations Corpus – April 2017